Since June, the number of COVID-19 infections started rising again, as the most transmissible omicron variant started picking up delta variant mutations...
Pierre A. Morgon, PharmD, LL.M, MBA, managing director at CanSino Biologics Europe, tells us about Convidecia, a single The post CanSinoBIO developed a...
- by New Deal democratThe CDC’s variant proportions data for this past week is out, and it shows that combined BA.4&5 made up slightly over 80%...
In a busy 24 hours of launches, Flagship Pioneering announced Apriori Bio, which utilizes artificial intelligence to predict virus activity and variant...
Now An Outbreak Of The Marburg Virus Has Begun Authored by Michael Snyder via The Economic Collapse blog, Why are so many unusual outbreaks...
PHILADELPHIA — (July 7, 2022) — Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical, Biological,...
Inflammatory disease drug developers would rather block a discrete step in a multistep inflammatory process—the equivalent of blocking a narrow mountain...
In the second of a three-part series, Ben Hargreaves looks at the importance of early-stage research into various The post Preventing the next pandemic:...
Army scientists and industry partners were among the first to demonstrate that messenger RNA (mRNA)—the technology recently used in COVID-19 vaccines...
As COVID-19 dies down in headlines, re-infection worries are stepping in to remind people of the risks of contracting the highly infectious virus. Numerous...
CHAMPAIGN, Ill. — When the coronavirus causing COVID-19 infects human cells, the cell’s protein-processing machinery makes modifications to the spike...
A study from the National Institutes of Health describes the immune response triggered by COVID-19 infection that damages the brain’s blood vessels and...
Convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or...
Is it time for a new generation of COVID vaccines? Here’s where the research is at.
A new immunochromatographic test provides a rapid, painless, easy to use, alternative for the simultaneous detection of SARS-CoV-2 IgM and IgG antibodies...
*Click here to watch “The hunt for COVID-19 variants” video Credit: UT Southwestern Medical Center *Click here to watch “The hunt for COVID-19 variants”...
Emerging Omicron subvariants BA.2.12.1, BA.4 and BA.5 are inhibited less efficiently by antibodies Credit: Image: Markus Hoffmann Emerging Omicron subvariants...
Tokyo, Japan – Despite significant and stunning advances in vaccine technology, the COVID-19 global pandemic is not over. A key challenge in limiting...
The experts agree — the pandemic is not over. Infections are ticking up again, fueled by the new variants our immune systems are ill prepared for....
Amid choppy markets, could there be potential in these top biotech stocks? The post 5 Top Biotech Stocks To Watch In July 2022 appeared first on...
With an ever-expanding menu of assays and products that are germane to the precision medicine landscape we are delighted to be producing this informative...
Memory B cells in the lungs consist of two transcriptionally distinct subsets localized strategically in the bronchial niche. ‘‘Bona fide’’ virus-specific...
Three months separated from a disappointing readout of its Covid-19 vaccine, Icosavax is back with what it calls positive topline data for a different...
Future booster campaigns against COVID-19 should include vaccines with a component targeting the Omicron variant of SARS-CoV-2, according The post US panel...
By Benjamin Boettner Credit: Wyss Institute at Harvard University By Benjamin Boettner (BOSTON) — Today the Wyss Institute for Biologically Inspired...
Intuitively, we would assume that subsequent infections should be less severe. But this won’t always be the case.
On the horizon: A new omicron-focused version of the Moderna vaccine that may offer longer protection and a stronger immune response.
Innovation Pharmaceuticals Inc (OTCMKTS: IPIX) is moving steadily northbound with power after the Company reported Brilacidin, its defensin-mimetic drug...
Researchers at the University of Campinas (UNICAMP) in São Paulo state, Brazil, have resorted to a thoroughly unconventional method to treat COVID-19...
With the SARS-CoV-2 pandemic ongoing, researchers at University of California San Diego School of Medicine, in collaboration with the American Academy...